Ironwood: Q4 Financial Overview

Ironwood Pharmaceuticals Announces Fourth Quarter Results

Ironwood Pharmaceuticals Inc., headquartered in Boston, disclosed a fourth-quarter net loss of $2.3 million.

The company reported a loss of $0.01 per share for the quarter.

During this period, Ironwood generated $47.7 million in revenue.

Looking ahead, the pharmaceutical firm anticipates its annual revenue will fall between $450 million and $475 million.

This article was created by Automated Insights using information provided by Zacks Investment Research.